Impact of the high-definition multileaf collimator on linear accelerator-based intracranial stereotactic radiosurgery

James Tanyi, C. M. Kato, Yiyi Chen, Z. Chen, M. Fuss

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objectives: The impact of two multileaf collimator (MLC) systems for linear accelerator-based intracranial stereotactic radiosurgery (SRS) was assessed. Methods: 68 lesions formed the basis of this study. 2.5 mm leaf width plans served as reference. Comparative plans, with identical planning parameters, were based on a 5 mm leaf width MLC system. Two collimation strategies, with collimation fixed at 0° or 90° and optimised per arc or beam, were also assessed. Dose computation was based on the pencil beam algorithm with allowance for tissue heterogeneity. Plan normalisation was such that 100% of the prescription dose covered 95% of the planning target volume. Plan evaluation was based on target coverage and normal tissue avoidance criteria. Results: The median conformity index difference between the MLC systems ranged between 0.8% and 14.2%; the 2.5 mm MLC exhibited better dose conformation. The median reduction of normal tissue exposed to ≥100%, ≥50% and ≥25% of the prescription dose ranged from 13.4% to 29.7%, favouring the 2.5 mm MLC system. Dose fall-off was steeper for the 2.5 mm MLC system with an overall median absolute difference ranging from 0.4 to 1.2 mm. The use of collimation optimisation resulted in a decrease in differences between the MLC systems. The results demonstrated the dosimetric merit of the 2.5 mm leaf width MLC system over the 5 mm leaf width system, albeit small, for the investigated range of intracranial SRS targets. Conclusion: The clinical significance of these results warrants further investigation to determine whether the observed dosimetric advantages translate into outcome improvements.

Original languageEnglish (US)
Pages (from-to)629-638
Number of pages10
JournalBritish Journal of Radiology
Volume84
Issue number1003
DOIs
StatePublished - Jul 2011

Fingerprint

Particle Accelerators
Radiosurgery
Prescriptions

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Impact of the high-definition multileaf collimator on linear accelerator-based intracranial stereotactic radiosurgery. / Tanyi, James; Kato, C. M.; Chen, Yiyi; Chen, Z.; Fuss, M.

In: British Journal of Radiology, Vol. 84, No. 1003, 07.2011, p. 629-638.

Research output: Contribution to journalArticle

@article{d655ecfda6b948eb8505087e2efd4bbf,
title = "Impact of the high-definition multileaf collimator on linear accelerator-based intracranial stereotactic radiosurgery",
abstract = "Objectives: The impact of two multileaf collimator (MLC) systems for linear accelerator-based intracranial stereotactic radiosurgery (SRS) was assessed. Methods: 68 lesions formed the basis of this study. 2.5 mm leaf width plans served as reference. Comparative plans, with identical planning parameters, were based on a 5 mm leaf width MLC system. Two collimation strategies, with collimation fixed at 0° or 90° and optimised per arc or beam, were also assessed. Dose computation was based on the pencil beam algorithm with allowance for tissue heterogeneity. Plan normalisation was such that 100{\%} of the prescription dose covered 95{\%} of the planning target volume. Plan evaluation was based on target coverage and normal tissue avoidance criteria. Results: The median conformity index difference between the MLC systems ranged between 0.8{\%} and 14.2{\%}; the 2.5 mm MLC exhibited better dose conformation. The median reduction of normal tissue exposed to ≥100{\%}, ≥50{\%} and ≥25{\%} of the prescription dose ranged from 13.4{\%} to 29.7{\%}, favouring the 2.5 mm MLC system. Dose fall-off was steeper for the 2.5 mm MLC system with an overall median absolute difference ranging from 0.4 to 1.2 mm. The use of collimation optimisation resulted in a decrease in differences between the MLC systems. The results demonstrated the dosimetric merit of the 2.5 mm leaf width MLC system over the 5 mm leaf width system, albeit small, for the investigated range of intracranial SRS targets. Conclusion: The clinical significance of these results warrants further investigation to determine whether the observed dosimetric advantages translate into outcome improvements.",
author = "James Tanyi and Kato, {C. M.} and Yiyi Chen and Z. Chen and M. Fuss",
year = "2011",
month = "7",
doi = "10.1259/bjr/19726857",
language = "English (US)",
volume = "84",
pages = "629--638",
journal = "British Journal of Radiology",
issn = "0007-1285",
publisher = "British Institute of Radiology",
number = "1003",

}

TY - JOUR

T1 - Impact of the high-definition multileaf collimator on linear accelerator-based intracranial stereotactic radiosurgery

AU - Tanyi, James

AU - Kato, C. M.

AU - Chen, Yiyi

AU - Chen, Z.

AU - Fuss, M.

PY - 2011/7

Y1 - 2011/7

N2 - Objectives: The impact of two multileaf collimator (MLC) systems for linear accelerator-based intracranial stereotactic radiosurgery (SRS) was assessed. Methods: 68 lesions formed the basis of this study. 2.5 mm leaf width plans served as reference. Comparative plans, with identical planning parameters, were based on a 5 mm leaf width MLC system. Two collimation strategies, with collimation fixed at 0° or 90° and optimised per arc or beam, were also assessed. Dose computation was based on the pencil beam algorithm with allowance for tissue heterogeneity. Plan normalisation was such that 100% of the prescription dose covered 95% of the planning target volume. Plan evaluation was based on target coverage and normal tissue avoidance criteria. Results: The median conformity index difference between the MLC systems ranged between 0.8% and 14.2%; the 2.5 mm MLC exhibited better dose conformation. The median reduction of normal tissue exposed to ≥100%, ≥50% and ≥25% of the prescription dose ranged from 13.4% to 29.7%, favouring the 2.5 mm MLC system. Dose fall-off was steeper for the 2.5 mm MLC system with an overall median absolute difference ranging from 0.4 to 1.2 mm. The use of collimation optimisation resulted in a decrease in differences between the MLC systems. The results demonstrated the dosimetric merit of the 2.5 mm leaf width MLC system over the 5 mm leaf width system, albeit small, for the investigated range of intracranial SRS targets. Conclusion: The clinical significance of these results warrants further investigation to determine whether the observed dosimetric advantages translate into outcome improvements.

AB - Objectives: The impact of two multileaf collimator (MLC) systems for linear accelerator-based intracranial stereotactic radiosurgery (SRS) was assessed. Methods: 68 lesions formed the basis of this study. 2.5 mm leaf width plans served as reference. Comparative plans, with identical planning parameters, were based on a 5 mm leaf width MLC system. Two collimation strategies, with collimation fixed at 0° or 90° and optimised per arc or beam, were also assessed. Dose computation was based on the pencil beam algorithm with allowance for tissue heterogeneity. Plan normalisation was such that 100% of the prescription dose covered 95% of the planning target volume. Plan evaluation was based on target coverage and normal tissue avoidance criteria. Results: The median conformity index difference between the MLC systems ranged between 0.8% and 14.2%; the 2.5 mm MLC exhibited better dose conformation. The median reduction of normal tissue exposed to ≥100%, ≥50% and ≥25% of the prescription dose ranged from 13.4% to 29.7%, favouring the 2.5 mm MLC system. Dose fall-off was steeper for the 2.5 mm MLC system with an overall median absolute difference ranging from 0.4 to 1.2 mm. The use of collimation optimisation resulted in a decrease in differences between the MLC systems. The results demonstrated the dosimetric merit of the 2.5 mm leaf width MLC system over the 5 mm leaf width system, albeit small, for the investigated range of intracranial SRS targets. Conclusion: The clinical significance of these results warrants further investigation to determine whether the observed dosimetric advantages translate into outcome improvements.

UR - http://www.scopus.com/inward/record.url?scp=79959620158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959620158&partnerID=8YFLogxK

U2 - 10.1259/bjr/19726857

DO - 10.1259/bjr/19726857

M3 - Article

C2 - 20923911

AN - SCOPUS:79959620158

VL - 84

SP - 629

EP - 638

JO - British Journal of Radiology

JF - British Journal of Radiology

SN - 0007-1285

IS - 1003

ER -